Icelandic Heart Association, Iceland
Role in the project:
- Participant; contributor of data in WP1 (Status)
- Participant; contributor of data and task leader 8.2 in WP8 (Older Adult Health)
About Icelandic Heart Association:
The Icelandic Heart Association (IHA) is a non-profit research organization established 1967 focusing on the epidemiology and genetics of the most common diseases affecting man. Dr. Vilmundur Gudnason is the director with main research emphasis in cardiovascular genetics, Professor in Cardiovascular Genetics at the University of Iceland, and the principal investigator for the Age Gene/Environment Susceptibility (AGES) Reykjavik study of the elderly, Risk Evaluation For INfarct Estimates (REFINE) Reykjavik study and the prospective Reykjavik study. AGES is one of the five founding members of the CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology) consortium. CHARGE was formed to facilitate genome-wide association studies, meta-analyses and replication opportunities among multiple large population–based cohort studies. Over 270 peer-reviewed papers including many in Nature, Nature Genetics, Lancet, NEJM and JAMA have been published out of the IHA. For instance, the mean impact factor for the 65 papers published 2012 by the IHA research group was 15. A number of Masters and Doctoral students have gone through the post graduate program at the Icelandic Heart Association as well as students at universities in Iceland and other countries. Technical resources include US/CT/s, s,fMRI imaging center, high-throughput biochemical laboratory, MiSeq sequencing platform and TaqMan genotyping facility and a supercomputer IBM blade cluster. Expertise at IHA includes epidemiology, genetics, phenomics, systems biology and bioinformatics, database platforms, vascular- and neuro-imaging, biomarkers, pharmacogenomics, risk assessment.